The manufacturer notifies Health Canada that in 30 days they're not going to make it anymore...The Globe and Mail recently reported that about 1,000 heart patients were in treatment limbo some facing complex, open-heart surgery after Sanofi Canada discontinued disopyramide, citing weakened demand....
FULL ARTICLE AT The Globe and Mail